Literature DB >> 28839975

Editorial on: multidisciplinary therapy of marginally operable stage IIIA non-small cell lung cancer.

Wanpu Yan1,2, David R Jones1.   

Abstract

Entities:  

Year:  2017        PMID: 28839975      PMCID: PMC5542974          DOI: 10.21037/jtd.2017.06.105

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

2.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Authors:  Walter J Curran; Rebecca Paulus; Corey J Langer; Ritsuko Komaki; Jin S Lee; Stephen Hauser; Benjamin Movsas; Todd Wasserman; Seth A Rosenthal; Elizabeth Gore; Mitchell Machtay; William Sause; James D Cox
Journal:  J Natl Cancer Inst       Date:  2011-09-08       Impact factor: 13.506

Review 3.  Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Transl Lung Cancer Res       Date:  2014-08

4.  Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973).

Authors:  José Belderbos; Lon Uitterhoeve; Nico van Zandwijk; Huub Belderbos; Patrick Rodrigus; Paul van de Vaart; Allan Price; Nico van Walree; Catherine Legrand; Sonia Dussenne; Harry Bartelink; Giuseppe Giaccone; Caro Koning
Journal:  Eur J Cancer       Date:  2006-11-03       Impact factor: 9.162

5.  Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Frank C Detterbeck; Michael A Jantz; Michael Wallace; Johan Vansteenkiste; Gerard A Silvestri
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

6.  Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Authors:  Kai-Lin Yang; Yih-Chen Chang; Hui-Ling Ko; Mau-Shin Chi; Hsin-Ell Wang; Pei-Sung Hsu; Chen-Chun Lin; Diana Yu-Wung Yeh; Shang-Jyh Kao; Jiunn-Song Jiang; Kwan-Hwa Chi
Journal:  Clin Lung Cancer       Date:  2016-06-08       Impact factor: 4.785

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.